Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, was 19 years old.Colorectal cancer used to be considered a cancer of older ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

Colorectal cancer was once considered primarily a disease of aging. But rates are now on the rise among younger adults. Since 2011, colon cancer rates among people younger than 50 have increased by ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...

Huntsman Cancer Institute recommends all individuals start regular colorectal cancer screenings at age 45. Colorectal cancer screenings help detect colon and rectal cancer early when it is easier to ...

The first blood test to screen for colorectal cancer could be approved this year — raising the potential to drastically increase the number of people diagnosed with the second-highest cause of cancer ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

INDIANAPOLIS (WISH) – This week, the United States Food and Drug Administration approved Guardant’s Shield blood test to screen for colon cancer in average-risk Americans 45 to 75 years old.

A colonoscopy is an exam that lets your physician see your entire colon. Before the test, your health care team will give you instructions for how to clear your colon of any stool. This process is ...

Colon cancer remains a significant health concern, particularly within the Black community, where the disease disproportionately affects individuals. A recent study led by researcher Adjoa ...